Evidence map›Paper›PMID 38610048›Full record

ArticleImmunity & ageing : I & A2024

Role of germinal center and CD39

Rocío Pastor, Juliana Puyssegur, M Paula de la Guardia, Lindybeth Sarmiento Varón, Gladys Beccaglia, Nicolás Spada, Andrea Paes de Lima, M Soledad Collado, Andrés Blanco, Isabel Aspe Scetti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Immunity & ageing : I & A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Rocío PastorInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.
Juliana PuyssegurInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.
M Paula de la GuardiaInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.
Lindybeth Sarmiento VarónInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.
Gladys BeccagliaDepartment of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina.
Nicolás SpadaDepartment of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina.
Andrea Paes de LimaDepartment of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina.
M Soledad ColladoInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.
Andrés BlancoInstitute of Otolaryngology Arauz, Buenos Aires, Argentina.
Isabel Aspe ScettiInstitute of Otolaryngology Arauz, Buenos Aires, Argentina.
M Elena ArabolazaPediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina.
Bibiana PaoliPediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina.
Fernando ChirdoDepartment of Biological Sciences, Faculty of Exact Sciences, Institute of Immunological and Physiopathological studies (IIFP), University of La Plata (UNLP), National Council for Scientific and Technological Research (CONICET), La Plata, Argentina.
Eloísa AranaInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina. eloarana@yahoo.com.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · ARHospital de Clínicas "José de San Martín" · ARCentro Científico Tecnológico - San Juan · ARUniversidad Nacional de La Plata · AR

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT 2019-0068CONICET PIP 0474Universidad de Buenos Aires UBACYT 20720170100004BA
6 · The paper itself

Abstract

backgroundThe tonsils operate as a protection ring of mucosa at the gates of the upper aero-digestive tract. They show similarities with lymph nodes and participate as inductive organs of systemic and mucosal immunity. Based on the reduction of their size since puberty, they are thought to experience involution in adulthood. In this context, we have used tonsillar mononuclear cells (TMC) isolated from patients at different stages of life, to study the effect of ageing and the concomitant persistent inflammation on these immune cells.

resultsWe found an age-dependent reduction in the proportion of germinal center B cell population (B

conclusionsThis paper sheds light on the changing aspects of the immune cellular landscape, over the course of time and constant exposure, at the entrance of the respiratory and digestive systems. Our findings support the notion that there is a re-modelling of the immune functionality of the excised tonsils over time. They are indicative of a transition from an effector type of immune response, typically oriented to reduce pathogen burden early in life, to the development of an immunosuppressive microenvironment at later stages, when tissue damage control gets critical provided the time passed under immune attack. Noteworthy, when isolated from such histologic microenvironment, older tonsillar B cells seem to level their proliferation capacity with the younger ones. Understanding these features will not only contribute to comprehend the differences in susceptibility to pathogens among children and adults but would also impact on vaccine developments intended to target these relevant mucosal sites.

Indexed as

AgeingImmunityInflammationMucosaRegulationTonsils

Identifiers

PMID38610048
PMCPMC11010345
OpenAlexW4394757145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.